Overview

Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer

Status:
Unknown status
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the response of docetaxel and gemcitabine in the neoadjuvant setting in women with locally advanced breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Korean Breast Cancer Study Group
Treatments:
Docetaxel
Gemcitabine